leisure time -WSS

leisure time

author：knowledge 2025-09-27 13:04:18 - browse：17

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： WuXi Biologics execs register to lobby as Congress comes for the company

explore

Wikipedia

WSS

Warren pushes Witty on UnitedHealth's control over physicians

Most antidepressants don't work on kids, teens, study finds

Brain MRIs reveal impact of 'toxic stress' on Black children

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Hottest summer in 2,000 years puts focus on extreme heat, health

Lilly’s weekly insulin works as well as daily products, new studies show

entertainment

leisure time

hotspot

Supreme Court strikes down use of affirmative action

Novel spinal cord stimulator treats paralysis without surgery

Apple is now the first public company to be valued at $3 trillion

As billionaires fund anti

Medicare proposal to cover medical devices draws a mixed reaction

How a small hospital in rural Puerto Rico survived Hurricane Maria

Supreme Court strikes down use of affirmative action

HHS's proposed rule does nothing to address the climate crisis

Jerome Adams on the need for new antivirals for Covid

HHS's proposed rule does nothing to address the climate crisis

focus

Chemotherapy before breast cancer surgery might fuel metastasis

ALS treatment from Biogen, Ionis fails in study

Obesity drug from Roche shows promise in early study

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Obesity drug from Roche shows promise in early study

As billionaires fund anti

explore

explore

Wikipedia

Wikipedia